The Bicalutamide 150 Mg Early Prostate Cancer Program: Findings of the North American Trial at 7.7-Year Median Followup-Reference-Cited by-同舟云学术

The Bicalutamide 150 Mg Early Prostate Cancer Program: Findings of the North American Trial at 7.7-Year Median Followup

Author:

McLeod David G.¹,See William A.²,Klimberg Ira³,Gleason Donald⁴,Chodak Gerald⁵,Montie James⁶,Bernstein Gregory¹,Morris Clive⁷,Armstrong Jonathon⁷,

Affiliation:

1. Urology Service, Walter Reed Army Medical Center, Washington, D. C.

2. Department of Urology, Medical College of Wisconsin, Milwaukee, Wisconsin

3. Urology Center of Florida, Ocala, Florida

4. Advanced Clinical Therapeutics, Inc., Tucson, Arizona, Prostate

5. Urology Health Center, Weiss Memorial Hospital, Chicago, Illinois

6. Urology Section, University of Michigan Health System, Ann Arbor, Michigan

7. AstraZeneca, Macclesfield, Cheshire, United Kingdom

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference16 articles.

1. Trends in the use of radical prostatectomy for treatment of prostate cancer;Ellison;Eff Clin Pract,1999

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献